At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CJMB Callan JMB Inc.
Trading 04-22 11:56:59 EDT
1.15
-0.01
-0.86%
High
1.25
Low
1.15
Vol
21.62K
Open
1.25
D1 Closing
1.16
Amplitude
8.62%
Mkt Cap
6.47M
Tradable Cap
1.60M
Total Shares
5.63M
T/O
25.58K
T/O Rate
1.55%
Tradable Shares
1.39M
P/B
--
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
Loading ...
News
New Post(s)
Profile
Callan JMB announces The Atlas Complex in Alabama
TIPRANKS · 04-20 22:41
Callan JMB announces The Atlas Complex in Alabama
Callan JMB signs partnership agreement with India’s Walker’s Pharmaceuticals for Atlas Complex
Reuters · 04-20 20:05
Callan JMB signs partnership agreement with India’s Walker’s Pharmaceuticals for Atlas Complex
Callan Jmb Inc - Intends to Pursue Foreign-Trade Zone Subzone Designation for Atlas Complex
THOMSON REUTERS · 04-20 20:05
Callan Jmb Inc - Intends to Pursue Foreign-Trade Zone Subzone Designation for Atlas Complex
Callan Jmb Inc - Atlas Complex Expected to Bring 250–300 Jobs and Long-Term Capital Investment to Marion
THOMSON REUTERS · 04-20 20:05
Callan Jmb Inc - Atlas Complex Expected to Bring 250–300 Jobs and Long-Term Capital Investment to Marion
Callan Jmb Inc - Announces Atlas Complex, 150 Acre Campus in Alabama for Pharmaceutical Onshoring
THOMSON REUTERS · 04-20 20:05
Callan Jmb Inc - Announces Atlas Complex, 150 Acre Campus in Alabama for Pharmaceutical Onshoring
Callan Jmb: Complaint Filed by Eddie Patent Holdings Does Not Impact Operations, Strategic Partnerships, or Ongoing Projects
THOMSON REUTERS · 04-18
Callan Jmb: Complaint Filed by Eddie Patent Holdings Does Not Impact Operations, Strategic Partnerships, or Ongoing Projects
Callan JMB faces lawsuit filed by Eddie Patent Holdings in Texas federal court
Reuters · 04-18
Callan JMB faces lawsuit filed by Eddie Patent Holdings in Texas federal court
Callan JMB gets Nasdaq notice for falling below $2.5 million equity requirement
Reuters · 04-11
Callan JMB gets Nasdaq notice for falling below $2.5 million equity requirement
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
GlobeNewswire · 04-07
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
Callan JMB FY25 operating loss widens to $7.0 million; revenue falls to $5.7 million
Reuters · 04-01
Callan JMB FY25 operating loss widens to $7.0 million; revenue falls to $5.7 million
Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update
GlobeNewswire · 04-01
Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update
Callan JMB to provide oversight for JKB-122 manufacturing scale-up
TIPRANKS · 03-27
Callan JMB to provide oversight for JKB-122 manufacturing scale-up
Callan JMB joins DifGen, Aveva, Attune Biotech, SGP in JKB-122 immune platform scale-up collaboration; provides independent manufacturing and supply chain oversight
Reuters · 03-27
Callan JMB joins DifGen, Aveva, Attune Biotech, SGP in JKB-122 immune platform scale-up collaboration; provides independent manufacturing and supply chain oversight
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
GlobeNewswire · 03-27
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
Top Executive Makes Bold Insider Move at Callan JMB, Inc.
TIPRANKS · 03-27
Top Executive Makes Bold Insider Move at Callan JMB, Inc.
Callan JMB; Chief Medical Officer David J. Croyle acquires 10,195 common shares valued at $17,841
Reuters · 03-27
Callan JMB; Chief Medical Officer David J. Croyle acquires 10,195 common shares valued at $17,841
Callan JMB, Attune Biotech partner for clinical trials for lodonal
TIPRANKS · 03-11
Callan JMB, Attune Biotech partner for clinical trials for lodonal
Callan JMB Inc. partners with Attune Biotech to oversee lodonal IND manufacturing and quality control
Reuters · 03-11
Callan JMB Inc. partners with Attune Biotech to oversee lodonal IND manufacturing and quality control
Callan Jmb Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s Ind Clinical Trials for Lodonal™ in the Treatment of Long Covid
THOMSON REUTERS · 03-11
Callan Jmb Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s Ind Clinical Trials for Lodonal™ in the Treatment of Long Covid
Callan JMB CEO Wayne Williams to Attend 50th International GMP Conference
Reuters · 03-02
Callan JMB CEO Wayne Williams to Attend 50th International GMP Conference
Introduction
Company Name.
Callan JMB Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--
{"stockData":{"symbol":"CJMB","market":"US","secType":"STK","nameCN":"Callan JMB Inc.","latestPrice":1.15,"timestamp":1776873383718,"preClose":1.16,"halted":0,"volume":21623,"delay":0,"changeRate":-0.008620689655172422,"floatShares":1394700,"shares":5627368,"eps":-1.818961,"marketStatus":"Trading","change":-0.01,"latestTime":"04-22 11:56:59 EDT","open":1.25,"high":1.25,"low":1.15,"amount":25575.571960399997,"amplitude":0.086207,"askPrice":1.17,"askSize":34,"bidPrice":1.14,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.818961,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1776888000000},"marketStatusCode":2,"adr":0,"listingDate":1738731600000,"exchange":"NASDAQ","adjPreClose":1.16,"preHourTrading":{"tag":"盘前","latestPrice":1.1816,"preClose":1.16,"latestTime":"08:29 EDT","volume":294,"amount":356.5557912,"timestamp":1776860975156,"change":0.0216,"changeRate":0.018621,"amplitude":0.172414},"postHourTrading":{"tag":"盘后","latestPrice":1.18,"preClose":1.16,"latestTime":"19:29 EDT","volume":582,"amount":680.32,"timestamp":1776814142817,"change":0.02,"changeRate":0.017241,"amplitude":0.034483},"volumeRatio":0.594121},"requestUrl":"/m/hq/s/CJMB/wiki","defaultTab":"wiki","newsList":[{"id":"2628248107","title":"Callan JMB announces The Atlas Complex in Alabama","url":"https://stock-news.laohu8.com/highlight/detail?id=2628248107","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628248107?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:41","pubTimestamp":1776696119,"startTime":"0","endTime":"0","summary":"Callan JMB (CJMB) announced Atlas Complex by Callan JMB, a planned 150 acre campus in Marion, Alabama designed to support an increase of pharmaceut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/callan-jmb-announces-the-atlas-complex-in-alabama-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/callan-jmb-announces-the-atlas-complex-in-alabama-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4131","AFH","CJMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628744740","title":"Callan JMB signs partnership agreement with India’s Walker’s Pharmaceuticals for Atlas Complex","url":"https://stock-news.laohu8.com/highlight/detail?id=2628744740","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628744740?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:05","pubTimestamp":1776686733,"startTime":"0","endTime":"0","summary":"Callan JMB entered partnership agreement with Walker's Pharmaceuticals of India to anchor Atlas Complex campus in Marion, Alabama.Walker’s becomes first on-site international partner for planned 150-acre campus aimed at capturing pharmaceutical onshoring demand.Callan JMB will lead activation, commercialization, expansion, and ongoing site management with Monarch Property Management.Project targets integrated early-stage production support, QA/QC, cold-chain logistics, and domestic distribution on one campus.Atlas Complex expected to support 250-300 jobs in Marion over time.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL13fKNy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2210149790.SGD","LU2095319765.USD","BK4588","BK4585","NDAQ","BK4131","SG9999014013.SGD","IE00BN0W2W23.USD","LU2210150020.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","CJMB","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628874025","title":"Callan Jmb Inc - Intends to Pursue Foreign-Trade Zone Subzone Designation for Atlas Complex","url":"https://stock-news.laohu8.com/highlight/detail?id=2628874025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628874025?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:05","pubTimestamp":1776686712,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN4130US:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CJMB","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628740259","title":"Callan Jmb Inc - Atlas Complex Expected to Bring 250–300 Jobs and Long-Term Capital Investment to Marion","url":"https://stock-news.laohu8.com/highlight/detail?id=2628740259","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628740259?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:05","pubTimestamp":1776686712,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN4130US:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CJMB","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628740230","title":"Callan Jmb Inc - Announces Atlas Complex, 150 Acre Campus in Alabama for Pharmaceutical Onshoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2628740230","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628740230?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:05","pubTimestamp":1776686712,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN4130US:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4131","CJMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628829947","title":"Callan Jmb: Complaint Filed by Eddie Patent Holdings Does Not Impact Operations, Strategic Partnerships, or Ongoing Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2628829947","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628829947?lang=en_us&edition=fundamental","pubTime":"2026-04-18 05:08","pubTimestamp":1776460099,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nFWN4100XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CJMB","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628782563","title":"Callan JMB faces lawsuit filed by Eddie Patent Holdings in Texas federal court","url":"https://stock-news.laohu8.com/highlight/detail?id=2628782563","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628782563?lang=en_us&edition=fundamental","pubTime":"2026-04-18 05:00","pubTimestamp":1776459619,"startTime":"0","endTime":"0","summary":"Callan JMB faces lawsuit filed by Eddie Patent Holdings in US District Court for Northern District of Texas.Callan JMB said litigation does not affect operations, strategic partnerships, or ongoing projects.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDLcdgb0v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CJMB","BK4112","BK4588","IE00B64PRP62.GBP","LU2210150020.SGD","NDAQ","IE00B3QW5Z07.USD","BK4585","SG9999014005.SGD","SG9999014021.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU0314104364.USD","LU2095319765.USD","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","BK4131","IE00BN0W2T93.GBP","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626143594","title":"Callan JMB gets Nasdaq notice for falling below $2.5 million equity requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626143594","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626143594?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:01","pubTimestamp":1775854885,"startTime":"0","endTime":"0","summary":"Callan JMB received Nasdaq notice on April 7, 2026 citing non-compliance with Listing Rule 5550 minimum $2.5 million stockholders’ equity requirement.Nasdaq set May 22, 2026 deadline for submission of plan to regain compliance.Acceptance of plan could allow up to 180 days from notice date, extending compliance window to Oct. 4, 2026.Common stock continues trading on Nasdaq Capital Market under symbol CJMB with no immediate impact.Risk of delisting remains if plan is rejected or compliance is not restored by deadline.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Callan JMB Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL8HP8NG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CJMB","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625895584","title":"Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer","url":"https://stock-news.laohu8.com/highlight/detail?id=2625895584","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625895584?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:45","pubTimestamp":1775565900,"startTime":"0","endTime":"0","summary":"Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its Established Emergency Preparedness Network SPRING BRANCH, Texas, April 07, 2026 (GLOBE N","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/07/3269169/0/en/Callan-JMB-Successfully-Deploys-Rapid-Redistribution-of-Critical-Pharmaceuticals-to-Combat-Localized-Disease-Outbreaks-for-Longstanding-Customer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","CJMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624537908","title":"Callan JMB FY25 operating loss widens to $7.0 million; revenue falls to $5.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624537908","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624537908?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:08","pubTimestamp":1774987704,"startTime":"0","endTime":"0","summary":"Callan JMB posted a net loss of $8.0 million for 2025.Revenue fell 12.8% to $5.7 million, due to lower demand for emergency preparedness services from some state and local governments.Operating loss widened to $7.0 million as SG&A climbed to $8.6 million.Business updates included an agreement with Attune Biotech covering manufacturing oversight, quality, and deployment, alongside expansion efforts in pharmaceutical logistics and U.S. onshoring initiatives.Wayne Williams said focus for the rest of 2026 includes strengthening core infrastructure, scaling readiness capabilities, and advancing growth initiatives in healthcare and food logistics.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL5YyT3n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BN0W2W23.USD","LU0314104364.USD","BK4112","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4131","SG9999014039.USD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","CJMB","BK4588","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","LU2095319765.USD","SG9999014005.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624119537","title":"Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2624119537","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624119537?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:05","pubTimestamp":1774987500,"startTime":"0","endTime":"0","summary":"The Company Deepened its Government Relationships at Both State and Federal Levels, Particularly to Support Onshoring Initiatives, While Reinforcing the Strength and Stability of Core Emergency Prepar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/31/3266026/0/en/Callan-JMB-Reports-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","CJMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622225828","title":"Callan JMB to provide oversight for JKB-122 manufacturing scale-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2622225828","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622225828?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:10","pubTimestamp":1774617038,"startTime":"0","endTime":"0","summary":"Callan JMB (CJMB) announced its role as an independent infrastructure and oversight partner in a collaboration led by DifGen Pharmaceuticals and Av...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/callan-jmb-to-provide-oversight-for-jkb-122-manufacturing-scale-up-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/callan-jmb-to-provide-oversight-for-jkb-122-manufacturing-scale-up-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4131","CJMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622821978","title":"Callan JMB joins DifGen, Aveva, Attune Biotech, SGP in JKB-122 immune platform scale-up collaboration; provides independent manufacturing and supply chain oversight","url":"https://stock-news.laohu8.com/highlight/detail?id=2622821978","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622821978?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:45","pubTimestamp":1774615527,"startTime":"0","endTime":"0","summary":"Callan JMB joins DifGen, Aveva, Attune Biotech, SGP in JKB-122 immune platform scale-up collaboration; provides independent manufacturing and supply chain oversight. Callan JMB will act as an independent infrastructure and oversight partner in a collaboration led by DifGen Pharmaceuticals and Aveva Drug Delivery Systems, alongside Attune Biotech and SGP Holdings.The collaboration supports U.S.-based technology transfer, formulation development, and manufacturing scale-up for the JKB-122 immune restoration platform.Callan JMB’s scope includes independent validation of manufacturing, quality systems, and supply chain operations as the program advances toward Phase 2b/3 development.The work also includes alignment with federal standards associated with BARDA, the U.S. Department of Defense, and the U.S. Department of Veterans Affairs.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL2BDbgr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BN0W2V16.EUR","LU2095319765.USD","CJMB","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4131","BK4588","LU2210150020.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","NDAQ","BK4585","LU2210149790.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622147821","title":"Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement","url":"https://stock-news.laohu8.com/highlight/detail?id=2622147821","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622147821?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:45","pubTimestamp":1774615500,"startTime":"0","endTime":"0","summary":"Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale across multiple indications SPRING BRANCH, Texas, March 27, 2026 (GLOBE ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/27/3263766/0/en/Callan-JMB-Supports-U-S-Scale-Up-of-Multi-Indication-Immune-Platform-with-Phase-2b-3-Advancement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","BK4585","BK4550","BK4196","BK4131","AIH","VHT","CJMB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622581694","title":"Top Executive Makes Bold Insider Move at Callan JMB, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2622581694","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622581694?lang=en_us&edition=fundamental","pubTime":"2026-03-27 10:02","pubTimestamp":1774576949,"startTime":"0","endTime":"0","summary":"New insider activity at Callan JMB, Inc. ( ($CJMB) ) has taken place on March 26, 2026. Callan JMB, Inc. saw a notable insider move as Chief Market...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-insider-move-at-callan-jmb-inc-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-insider-move-at-callan-jmb-inc-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CJMB","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622940118","title":"Callan JMB; Chief Medical Officer David J. Croyle acquires 10,195 common shares valued at $17,841","url":"https://stock-news.laohu8.com/highlight/detail?id=2622940118","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622940118?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:20","pubTimestamp":1774563610,"startTime":"0","endTime":"0","summary":"Callan JMB reported that Chief Medical Officer David J. Croyle, a 10% owner, acquired 10,195 shares of common stock.The shares were purchased at a price of USD 1.75 per share.Beneficial ownership following the reported transaction was 800,000 shares held indirectly through a rollover IRA.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Callan JMB Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL602ms4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Callan JMB; Chief Medical Officer David J. Croyle acquires 10,195 common shares valued at $17,841","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CJMB","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618940398","title":"Callan JMB, Attune Biotech partner for clinical trials for lodonal","url":"https://stock-news.laohu8.com/highlight/detail?id=2618940398","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618940398?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:55","pubTimestamp":1773233755,"startTime":"0","endTime":"0","summary":"Callan JMB (CJMB) has agreed with Biostax Corp d/b/a Attune Biotech to support its investigational new drug clinical trials for the treatment of Po...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/callan-jmb-attune-biotech-partner-for-clinical-trials-for-lodonal-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/callan-jmb-attune-biotech-partner-for-clinical-trials-for-lodonal-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XBI","BK4581","BK4131","CJMB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618947966","title":"Callan JMB Inc. partners with Attune Biotech to oversee lodonal IND manufacturing and quality control","url":"https://stock-news.laohu8.com/highlight/detail?id=2618947966","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618947966?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:45","pubTimestamp":1773233120,"startTime":"0","endTime":"0","summary":"Callan JMB agreed with Attune Biotech to oversee manufacturing and quality control for Attune’s investigational new drug clinical trials of lodonal for Long COVID. Under the agreement, Callan JMB will provide independent oversight of manufacturing, quality assurance and control, and deployment operations. Services include contract manufacturing organization qualification and validation, batch record review, and supply chain verification. The collaboration covers IND 181314 for JKB-122 , for which Attune plans a randomized, double-blind, placebo-controlled, multi-center Phase 2b/3 trial in adults with PASC.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL90mfMf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CJMB","IE00BGHQF748.EUR","LU2210149790.SGD","SG9999014013.SGD","BK4588","LU0314104364.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014021.USD","BK4131","IE00BKPKM429.USD","LU2210150020.SGD","BK4585","NDAQ","BK4112","SG9999014039.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618947959","title":"Callan Jmb Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s Ind Clinical Trials for Lodonal™ in the Treatment of Long Covid","url":"https://stock-news.laohu8.com/highlight/detail?id=2618947959","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618947959?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:45","pubTimestamp":1773233100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nTUABJDHK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CJMB","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616330451","title":"Callan JMB CEO Wayne Williams to Attend 50th International GMP Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2616330451","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616330451?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:45","pubTimestamp":1772459111,"startTime":"0","endTime":"0","summary":"Callan JMB CEO Wayne Williams to Attend 50th International GMP Conference Callan JMB Inc. said CEO Wayne Williams has been invited to attend the 50th International GMP Conference in Athe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL3tjvSD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CJMB","IE00BGHQF748.EUR","LU2210149790.SGD","SG9999014013.SGD","BK4588","LU0314104364.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014021.USD","BK4131","IE00BKPKM429.USD","LU2210150020.SGD","BK4585","NDAQ","BK4112","SG9999014039.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://callanjmb.com","stockEarnings":[{"period":"1week","weight":0.0642},{"period":"1month","weight":-0.4051},{"period":"3month","weight":-0.5857},{"period":"6month","weight":-0.7225},{"period":"1year","weight":-0.7198},{"period":"ytd","weight":0.045}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":0.0856},{"period":"3month","weight":0.0273},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.3701},{"period":"ytd","weight":0.0325}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Callan JMB Inc.","nameEN":"Callan JMB Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Callan JMB Inc.(CJMB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Callan JMB Inc.(CJMB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Callan JMB Inc.,CJMB,Callan JMB Inc.股票,Callan JMB Inc.股票老虎,Callan JMB Inc.股票老虎国际,Callan JMB Inc.行情,Callan JMB Inc.股票行情,Callan JMB Inc.股价,Callan JMB Inc.股市,Callan JMB Inc.股票价格,Callan JMB Inc.股票交易,Callan JMB Inc.股票购买,Callan JMB Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Callan JMB Inc.(CJMB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Callan JMB Inc.(CJMB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}